지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 278 - 293 (16page)
이용수
초록· 키워드
오류제보하기
The paradigm for the treatment of chronic hepatitis C (CHC) has been changed due to the development of direct acting antivirals (DAAs) of hepatitis C virus (HCV). The high sustained virologic response rate and ease of administration makes the DAAs approach ideal to contribute to the complete eradication of HCV. Currently, treatment options for individual patients vary depending on the genotype or subtype of HCV, presence or absence of liver cirrhosis, previous experience of antiviral treatment or resistance associated substitutions. Because of drug avalilability, cost-effectiveness, preference, compliance and greater possibility of desirable effects and presumed patient-important outcomes may vary between countries, treatment options for individual patients are different. The review focuses on the comparing the current treatment options for CHC in other continents with the 2017 Korea Association for the Study of the Liver guidelines.
목차
등록된 정보가 없습니다.
참고문헌 (59)
참고문헌 신청
2014 / KASL clinical practice guidelines: management of hepatitis C / Clin Mol Hepatol 20:89~136
2016 / KASL clinical practice guidelines: management of hepatitis C / Clin Mol Hepatol 22:76~139
Korea Association for the Study of the Liver / 0000 / KASL Clinical Practice Guidelines, Management of hepatitis C: Treatment of chronic hepatitis C
American Association for the Study of Liver Diseases / 0000 / HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
2017 / EASL Recommendations on Treatment of Hepatitis C 2016 / J Hepatol 66:153~194
2016 / KASL clinical practice guidelines: management of hepatitis C / Clin Mol Hepatol 22:76~139
Korea Association for the Study of the Liver / 0000 / KASL Clinical Practice Guidelines, Management of hepatitis C: Treatment of chronic hepatitis C
American Association for the Study of Liver Diseases / 0000 / HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
2017 / EASL Recommendations on Treatment of Hepatitis C 2016 / J Hepatol 66:153~194
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Clinical and Molecular Hepatology
2020 .01
-
Hepatitis C Viral Infection in Children: Updated Review
Pediatric Gastroenterology, Hepatology & Nutrition
2016 .01
-
Hepatitis C Virus and Antiviral Drug Resistance
Gut and Liver
2016 .01
-
Treatment Outcomes of HCV Infection in People Living with HIV: A Case Series from a Single Center in Korea
Infection and Chemotherapy
2024 .09
-
Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea : 2-center experience
Annals of Surgical Treatment and Research
2018 .09
-
Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study
Gut and Liver
2020 .01
-
Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
Clinical and Molecular Hepatology
2018 .01
-
The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
Clinical and Molecular Hepatology
2021 .01
-
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver Cirrhosis
Gut and Liver
2017 .01
-
The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment
Gut and Liver
2022 .11
-
What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?
Journal of Korean Medical Science
2019 .01
-
Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment
Clinical and Molecular Hepatology
2023 .01
-
Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C
Gut and Liver
2016 .01
-
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2018 .01
-
A Survey of the Knowledge of and Testing Rate for Hepatitis C in the General Population in South Korea
Gut and Liver
2020 .01
-
Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
Gut and Liver
2019 .01
-
Cost-effectiveness of chronic hepatitis C screening and treatment
Clinical and Molecular Hepatology
2022 .04
-
특수한 경우의 C형 간염 치료: 만성 콩팥병
대한내과학회지
2015 .01
-
Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
Clinical and Molecular Hepatology
2017 .01
-
Treatment Strategy on Hepatitis C Treatment In Liver Transplant Settings
Clinical Transplantation and Research
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0